Curaleaf Plans Hostile Takeover Bid for Aurora Cannabis After Board Rejects Talks
The bid carries a 45% premium and aims to create a global cannabis leader.
Already have an account? Sign in.
The bid carries a 45% premium and aims to create a global cannabis leader.
JOBY shares drop after new at-the-market (ATM) deal allows the company to sell up to $750 million in stock following the acquisition.
AC Immune’s ACI-7104 receives FDA Fast Track and IND clearance for early Parkinson’s. Phase 2 VacSYn trial can now expand to US sites.
ACV Auctions stock soars as company considers sale or partnership; no deal is imminent, sources say.